536 Prognostic Implications of Post-Percutaneous Intervention Troponin Rise in Non-ST Elevation Myocardial and Unstable Angina Patients

S. Das,Q. Tran,V. Moosavi,Q. Yang,N. Ariyarathna,A. Wheelahan,W. Ng,T. Harvey,P. Marley,A. Farshid

DOI: https://doi.org/10.1016/j.hlc.2020.09.543

2020-01-01

Abstract:Troponin elevation after percutaneous coronary intervention (PCI) is common but its prognostic significance remains uncertain. We aimed to study the relationship between the level of troponin elevation post-PCI and adverse events in non-ST-elevation myocardial infarction (NSTEMI) and unstable angina (UA) patients. A retrospective analysis of all patients who underwent PCI for NSTEMI and UA between 2014-2018 was carried out. Primary outcome was major adverse cardiovascular events (MACE) in 12 months. Contingency analysis for MACE with different post-PCI troponin values was carried out. Registry analysis revealed that 1506 patients with mean age of 66.3±23.06 years with a male predominance (74.8 %) underwent PCI for NSTEMI and UA presentations. Contingency analysis of MACE by post-PCI troponin at different cut-offs revealed that in the NSTEMI patients the post-PCI troponin level did not increase MACE and remained steady around 11% until the troponin level was >40000 ng/L when MACE increased to 15%. However, in UA patients, the MACE was steady around 7% till the troponin level was >1000 ng/L, after which the MACE increased steadily to 25% when troponin was >10000 ng/L. Our results suggest that post-procedure troponin rise >1000 ng/L was associated with higher rate of MACE in UA patients. There was no obvious association between level of troponin and MACE rate in NSTEMI patients, until the level was >40,000. The clinical significance and indeed the necessity of routine post-PCI troponin measurement requires further review.